Plain-English translation of NCT07604220 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Mayo Clinic are studying tiny particles in blood called exosomes to find new ways to track cardiac sarcoidosis — a rare inflammatory condition affecting the heart. By comparing blood samples from people with heart sarcoidosis and those without, the team hopes to discover unique markers that can tell doctors whether the disease is active or in remission.
Currently, doctors struggle to know when heart sarcoidosis is truly active versus dormant, which makes treatment decisions difficult. This research aims to develop a simple blood test that could reliably measure disease activity, helping doctors manage care more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll visit the Mayo Clinic Cardiac Sarcoid Clinic and donate blood samples, which researchers will store in a special collection (biobank) for analysis. Your participation also involves undergoing a heart imaging scan called an FDG-PET, which is likely already part of your standard medical care. The study team will follow your health status to understand whether your disease is active or inactive.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
United States
Enrollment target
~115 participants
Started
July 2026
Primary completion
July 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anna Pick
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.